Breast Cancer Resistance Protein
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Breast Cancer Resistance Protein Means in Everyday Medical Language
Breast Cancer Resistance Protein, often called BCRP, is a protein naturally found in many parts of the body such as the intestine, liver, brain, and placenta. Its main role is to help cells move substances like drugs and chemicals in and out. This helps protect normal cells by keeping harmful substances out and removing waste or extra chemicals. The protein was first found in breast cancer cells, which is why it has this name, but it is present in many types of cells and cancers.
Why BCRP Can Matter in Cancer Care
In some cancer cells, BCRP is found in higher amounts than usual. When this happens, the protein can pump anticancer drugs out of the cancer cells before the drugs can work effectively. This process is called drug resistance. Drug resistance can make cancer treatments less effective or cause them to stop working over time. Understanding BCRP helps doctors learn why some cancers do not respond well to certain medicines and guides research into new treatments that might block BCRP to improve drug effectiveness.
What Patients Might See or Hear About BCRP
Patients may hear about BCRP if their cancer is not responding as expected to treatment. Doctors might mention it when explaining why a particular drug is less effective or when discussing clinical trials testing new drugs that block BCRP. It can also appear in medical reports or treatment plans as part of understanding how the cancer behaves. Hearing the term can be confusing, but it is one factor among many that doctors consider when planning care.
What BCRP Does Not Automatically Mean
Finding BCRP in cancer cells does not mean treatment will definitely fail or that the cancer is untreatable. It is one of several factors that influence how cancer responds to therapy. Also, despite its name, BCRP is not only related to breast cancer but can be involved in other cancer types. It is important not to overinterpret the presence of BCRP without discussing its meaning with your care team.
How Doctors Use BCRP Information
Doctors may test for BCRP levels to understand drug resistance and help plan treatment. If resistance related to BCRP is suspected, they might consider different medicines or clinical trials that include drugs designed to block BCRP. This information helps tailor treatment to the individual’s cancer and may improve outcomes.
Common Questions to Ask Your Care Team
Patients and caregivers can ask questions like, "Is BCRP affecting my treatment?" or "Are there options to overcome drug resistance caused by BCRP?" Understanding how BCRP fits into the overall treatment plan can help patients feel more informed and involved in their care decisions.
How to Read the Term in Context
It is best to understand BCRP as part of a broader conversation about cancer treatment and drug resistance. Seeing the term in a report or discussion does not provide a full picture on its own. Always ask your care team to explain what it means for your specific situation.
Safety and Next Steps
This information about BCRP is educational and does not replace personalized medical advice. Each person’s cancer and treatment are unique, so it’s important to discuss any concerns or questions with your healthcare provider. If you come across the term BCRP in your medical information, the next step is to talk with your care team about what it means for your specific situation. They can explain how it might affect your treatment and what options are available to you.
Sources
Public source information used for this glossary entry includes: